Joining Moderna: purpose and motivation
What led you to join Moderna? And beyond the role itself, what did you feel you were coming to build?
For me, there were two fundamental elements. After working internationally for several years, I wanted to have an impact at home in Canada; I wanted to build and contribute to something bigger—here in Quebec.
At the same time, Moderna was embarking on an important journey to establish a manufacturing presence in Canada, strengthening local capabilities and resilience in biomanufacturing.
So when the opportunity arose, it wasn’t simply about building a new facility for Moderna—it’s never just bricks and mortar. It was about helping to anchor a transformative technology here: internalising capabilities, knowledge and expertise with immense potential.
Because the potential of the mRNA platform, in my view, is still far from fully realized.
At its core, leadership begins well before there is a facility to operate—it begins when there is nothing yet to run, only something to build. For me, that was the essence: contributing to something foundational, at home.
Building the team
Concretely, what did that look like on the ground for you as a leader? And when it came to building the team, what really mattered?
When I arrived in mid-2023, there were two of us on site. We were still working out of construction trailers. Between February 2023 and February 2024, we built the facility in one year, to the day. But beyond the physical construction, the real challenge was people.
People would say: ‘You have five people on site and you want to produce a vaccine—how are you going to do that?’
The reality is that when we opened the first roles—10 positions—we received over 300 applications from highly qualified candidates around the world. There was a remarkable diversity of profiles.
Technical expertise was a given — but mindset set us apart. I wasn’t chosen for deep mRNA specialization, but to help build a team where that expertise could come together and deliver.
I was chosen for my background in biopharmaceutical manufacturing, with mRNA a newer modality for me — highlighting our focus on assembling diverse, complementary expertise.
What we were looking for was:
• Curiosity
• Humility
• A sense of purpose and alignment with the meaning behind our work.
In a new environment, where many things are being built that don’t yet exist, expertise alone isn’t enough.
It is the combination of strong capabilities and the right mindset that allows teams to adapt, learn quickly and navigate challenges together. When people are aligned around a “why,” they can overcome challenges together.
From building to sustaining
At some point, building gives way to something else. When did you feel the shift between “moving things forward” (the building phase) and “making things last”? What changed for you?
The shift this year was from a project mindset to an operational one. During construction, we were driven by aggressive milestones and timelines. We worked intensely, but at a certain point, it became clear that this pace wasn’t sustainable. The biggest learning for me has been the importance of managing energy over the long term.
We then had to introduce more structure:
• Systems
• Processes
• Overall balance
The real turning point in leadership is when you move from producing results to building a system that consistently delivers them. I had to adjust my approach and adapt to situations that can vary.
I see myself as a shepherd: sometimes in front, sometimes behind, sometimes in the middle. At times, you need to give direction, and others, you need to protect the team.